Recent updates on Sintilimab in solid tumor immunotherapy

Liu, XH; Yi, Y

Yi, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China.; Yi, Y (corresponding author), Fudan Univ, Shanghai Med Sch, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Shanghai 200032, Peoples R China.

BIOMARKER RESEARCH, 2020; 8 (1):

Abstract

In recent years, there have been advancements in traditional patterns of tumor therapy with the adoption of immunotherapy. Its application with or wit......

Full Text Link